Multi-Drug Resistant Bacteria Carriage After Travel

Multi-Drug Resistant Bacteria Carriage After Travel: Comparison Between Patients Who Have Been Hospitalized in a Foreign Country, or Not During the Previous Year

During one month, from 1st to 30th November 2016, all patients admitted in one of the medical Dpt of our Hospital (Internal Medicine Dpt, Endocrinology, ICU) will be screened for multi-drug resistant bacteria carriage (after written consent). They will answer to a questionnaire about previous travel in a foreign country during the previous year, hospitalization or not during this travel.

Study Overview

• Status: Completed
• Conditions: Beta Lactam Resistant Bacterial Infection (Disorder)
• Intervention / Treatment: Biological: rectal swab for Multi-Drug resistant bacteria

Detailed Description

During one month, from 1st to 30th November 2016, all patients admitted in one of the medical Dpt of our Hospital (Internal Medicine Dpt, Endocrinology, ICU) will be screened for multi-drug resistant bacteria carriage (after written consent), regardless a travel in a foreign country during the past year, or not. They will answer to a questionnaire about previous travel in a foreign country during the previous year, hospitalization or not during this travel. The aim of the study will be to compare the rate of carriage of multi-drug resistant bacteria among previous travelers, or not.

• Study Type: Observational
• Enrollment (Actual): 300

Contacts and Locations

Study Locations

• France
  • Ile-de-France
    • Paris, Ile-de-France, France, 75475
      • URT, Hopital Lariboisiere

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (ADULT, OLDER_ADULT)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

All patients admitted in one of the medical Dpt of our Hospital who have travelled in a foreign country during the previous year

Description

Inclusion Criteria:

• All patients admitted in one of the medical Dpt of our Hospital who have travelled in a foreign country during the previous year

Exclusion Criteria:

• patients who were unable to give written consent

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Multi-Drug Resistant bacteria carriage rate	Multi-Drug Resistant bacteria carriage assessed by rectal swab	At admission in our Hospital

Collaborators and Investigators

• Sponsor: Hopital Lariboisière
• Investigators: Study Director: Pierre O Sellier, M.D., Ph.D., Hopital Lariboisière

Study record dates

Study Major Dates

• Study Start (ACTUAL): November 1, 2016
• Primary Completion (ACTUAL): December 1, 2016
• Study Completion (ACTUAL): December 1, 2016

Study Registration Dates

• First Submitted: March 18, 2018
• First Submitted That Met QC Criteria: March 18, 2018
• First Posted (ACTUAL): March 26, 2018

Study Record Updates

• Last Update Posted (ACTUAL): March 26, 2018
• Last Update Submitted That Met QC Criteria: March 18, 2018
• Last Verified: March 1, 2018

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Infections; Bacterial Infections and Mycoses; Bacterial Infections
• Other Study ID Numbers: MRB after travel

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO